Ambryon Biosciences

Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

Kumar et al. (2020). Nat MethodsResearch

CREATE selected AAV capsids without correcting for production bias. Multiplexed-CREATE added deep sequencing and a codon-replicated synthetic round-2 pool to a 7-mer AAV9 screen. It yielded AAV-PHP.V1, which transduced ~60% of cortical vasculature versus ~20% for AAV-PHP.eB.

Key findings

  • In the 3-mer-s AAV-PHP.B library, 150 to 200 capsids are brain-enriched; those also liver-depleted share Gly/Asp/Glu at position 1, Gly/Ser at position 2 (including PHP.eB's DG) and Ser/Asn/Pro at positions 9 to 11, defining an SNP family on PHP.B.

  • The strain dependence of CNS transduction by AAV-PHP.eB extends to the newer PHP.B-family variants AAV-PHP.V1 and AAV-PHP.N: neither transduces the CNS in BALB/cJ mice, while both transduce the brain of FVB/NJ mice, as they do in C57BL/6J mice.

  • AAV-PHP.C1 (RYQGDSV), C2 (WSTNAGY) and C3 (ERVGFAQ), unrelated to PHP.B, cross the blood-brain barrier with roughly equal CNS transduction in BALB/cJ and C57BL/6J mice, unlike AAV-PHP.eB, whose enhancement is absent in BALB/cJ, suggesting BBB-entry mechanisms lacking strain specificity.

  • Production in 293T cells selects an AAV9 7-mer-i motif with Asn at position 2, Ile/Thr/Val at position 4 and Lys/Arg at position 5; brain-enriched variants differ, favoring Pro at position 5 and Phe at position 6.

  • A Round-2 synthetic pool is more even than a PCR pool; in GFAP-Cre mice it yields about 1,700 positively enriched variants per brain library versus about 700, and about 90% of spike-in controls are enriched.

  • Enrichment scores of the two codon replicates of 8,462 Tek-Cre brain variants correlate only above about 0.3, which marks high-confidence signal over noise; for variants whose replicates agree, enrichment across tissues may be predictive of in vivo transduction.

  • The most enriched Round-2 brain variants across Tek-Cre, GFAP-Cre, SNAP25-Cre and Syn1-Cre mice share a motif (Thr1, Leu2, Pro5, Phe6, Lys/Leu7) resembling AAV-PHP.B's TLAVPFK; about 60 brain-enriched variants are depleted in all other organs.

  • AAV-PHP.V1 (TALKPFL) transduces about 60% of GLUT1+ cortical vasculature versus about 20% for AAV-PHP.eB and almost none for AAV9, and about 60% of cortical S100+ astrocytes, less efficiently than AAV-PHP.eB with a GfABC1D promoter.

  • AAV-PHP.V1 restricts expression to brain endothelial cells in Tek-Cre mice with CAG-DIO-EYFP, in Ai14 mice with Ple261-iCre, and in wild-type mice with a scAAV ubiquitous-promoter genome; the mechanism behind the scAAV specificity is unclear.

Author abstract

Recombinant adeno-associated viruses (rAAVs) are efficient, non-invasive gene delivery vectors via intravenous delivery, however, natural serotypes display a finite set of tropisms. To expand their utility, we evolved AAV capsids to efficiently transduce specific cell types in adult mouse brains. Building upon our previous Cre recombination-based AAV targeted evolution (CREATE) platform, we developed Multiplexed-CREATE (M-CREATE) to quickly and accurately identify variants of interest in a given selection landscape through multiple positive and negative selection criteria by incorporating next-generation sequencing, synthetic library generation, and a novel analysis pipeline. In vivo selections for brain endothelial cell-, astrocyte-, and neuron-transducing capsids have identified variants that can transduce the central nervous system broadly, exhibit bias toward vascular cells and astrocytes, target neurons with greater specificity, or cross the blood-brain barrier across diverse murine strains. Collectively, M-CREATE methodology accelerates the discovery of novel capsids for use in neuroscience and gene therapy applications.

Identifiers & revision